SFL’s CEO Shayesteh Fürst-Ladani and Head of Regulatory Affairs Anja Bührer, will participate in the upcoming virtual DIA 2020 Global Annual Meeting (14-18 June). SFL is looking forward to sharing its global expertise in science, healthcare, and regulation across pharmaceutical, biotechnology, and medical devices and discuss how innovative, safe and effective medical products can be developed to address patient needs. SFL will also host a virtual booth showcasing the services and support it can offer to partners and clients.

SFL provides strategic and operational support for projects covering all life-cycle stages from early development of and regulatory strategies for new healthcare products to regulatory maintenance and market access activities of approved products, utilizing its unique combination of expertise and a multi-disciplinary approach. In addition, SFL can also act as the Marketing Authorization Holder (MAH) for pharma companies, who do not have a registered subsidiary in the EU or Switzerland. Contact us to arrange a 1-1 meeting with Shayesteh or Anja during the DIA 2020 Global Annual Meeting.